8-K 1 tv514845_8k.htm FORM 8-K






Washington, D.C. 20549









Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported) February 27, 2019





(Exact name of registrant as specified in its charter)




  (State or other jurisdiction of incorporation)  
001-38365   47-1178401
(Commission File Number)   (IRS Employer Identification No.)

295 Madison Avenue, Suite 2400, New York, NY 10017

(Address of principal executive offices) (Zip Code)


Registrant's telephone number, including area code 917-289-1117




Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging Growth Company x


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨






Item 7.01.        Regulation FD Disclosure.


On February 27, 2019, Eyenovia, Inc. (the “Company”) presented a corporate update to analysts and investors. A copy of the corporate update is attached hereto as Exhibit 99.1 and is incorporated herein in by reference.


The information contained in, or incorporated into, Item 7.01, including the corporate update attached as Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.


Item 9.01.        Financial Statements and Exhibits.


(d)         Exhibits


Exhibit No.



99.1   Eyenovia, Inc. corporate update dated February 27, 2019.







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 


Date: February 27, 2019 By:

/s/ John Gandolfo

    Name:  John Gandolfo
    Title:  Chief Financial Officer